Dataset Information

Proteome of candida glabrata after Caspofungin exposure

ABSTRACT: Caspofungin resistance is a great concern, as the echinocandin drugs are recommended as first-line therapy for invasive candidiasis. Echinocandin resistance is conferred by mutations in FKS genes. Nevertheless, some pathways which regulate cellular stress responses could be crucial for enabling the evolution and maintenance of drug resistance. In this work, the first objective was to identify resistant mechanisms by whole genome sequencing in echinocandin-resistant C. glabrata. Then, studies of the proteomic response to caspofungin exposure and the analysis of the impact of calcineurin inhibitors on susceptibility, stress tolerance, biofilm formation, and pathogenicity in Galleria mellonella were conducted. The caspofungin resistant isolate only presented mutation in the FKS gene. Based on proteomic results, we identified 21 proteins whose abundance changed in response to caspofungin exposure. Some of these proteins are involved in wall biosynthesis, pathogenesis, and response to stress. Also, we showed that antifungal drugs in combination with CaM/Cal inhibitors could be an excellent therapeutic option, proved in an in-vitro and in-vivo model. Results, that could be potentially used to improve the outcomes of fungal diseases, especially now that antifungal resistance is increasing.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Candida Glabrata (yeast) (torulopsis Glabrata)

TISSUE(S): Blood

SUBMITTER: Concha Gil

LAB HEAD: Concha Gil

PROVIDER: PXD021578 | Pride | 2022-04-04

REPOSITORIES: Pride

ACCESS DATA

Publications

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.

Ceballos-Garzon Andres A Ceballos-Garzon Andres A Monteoliva Lucia L Gil Concha C Alvarez-Moreno Carlos C Vega-Vela Nelson E NE Engelthaler David M DM Bowers Jolene J Le Pape Patrice P Parra-Giraldo Claudia M CM

The Journal of antimicrobial chemotherapy 20220201 3

<h4>Background</h4>Echinocandin resistance represents a great concern, as these drugs are recommended as first-line therapy for invasive candidiasis. Echinocandin resistance is conferred by mutations in FKS genes. Nevertheless, pathways are crucial for enabling tolerance, evolution, and maintenance of resistance. Therefore, understanding the biological processes and proteins involved in the response to caspofungin may provide clues indicating new therapeutic targets.<h4>Objectives</h4>We determi ...[more]

PMID: 34893830

Similar Datasets

Project description:Aspergillus species are a leading cause of invasive fungal infections. As resistance to first-line therapy involving triazole antifungal agents is rising, second-line therapy with echinocandins is expanding. Resistance to echinocandins is well-established to result from amino acid substitutions in the echinocandin drug target β-(1,3)-D-glucan synthase encoded by the fks1 gene. Recently, we identified several high MIC clinical isolates of A. fumigatus from patients failing echinocandin therapy that did not contain any mutation in the fks1 gene, indicating that echinocandin resistance in these isolates results from an undefined mechanism. To explore possible new mechanisms of resistance, we used a lab-derived strain, RG101, with a nearly identical susceptibility phenotype, as a model system. This strain does not contain fks1 mutations but showed prominent resistance to the echinocandin class drug caspofungin (CAS), while remaining sensitive to other echinocandins, azoles and polyenes. Glucan synthase isolated from RG101 was fully sensitive to drug. Yet, exposure to CAS during its growth yielded a modified enzyme that was insensitive (4-log orders) in kinetic inhibition assays to CAS, as well as other echinocandins. This induction of cross-resistance by CAS was also observed in clinical isolates. To determine the nature of a presumptive posttranslational modification (PTM) of the enzyme, we analyzed whole enzyme PTMs, including the known hot-spot regions, for methylation, acetylation and phosphorylation. While we did not identify any PTMs linked to resistance, analysis of the lipid microenvironment of CAS-induced resistant enzyme revealed a prominent increase in the abundance of dihydrosphingosine (DhSph) and phytosphingosine (PhSph). Exogenous addition of DhSph and PhSph to sensitive enzyme in in vitro kinetic inhibition assays recapitulated the CAS insensitivity of the cellular-derived enzyme. To further examine induction of drug-induced resistance, we used an in vitro assay to demonstrate that CAS, but not other echinocandin class drugs, prominently induced the production of mitochondrial-derived Reactive Oxygen Species (ROS) in A. fumigatus. RNASeq evaluation of whole cells confirmed a ROS signature in cells treated with CAS. Dampening the formation of ROS by antimycin A or thiourea eliminated the induction of drug resistance by CAS. We conclude that CAS-induced formation of ROS promotes a cellular stress response that alters the composition of plasma membrane lipids surrounding glucan synthase, changing its enzymatic properties to make it insensitive to echinocandins. This stress-induced response constitutes a novel mechanism of echinocandin resistance in Aspergillus, with implications for drug resistance and/or tolerance mechanisms in other fungal pathogens.

Project description:Complex scientific experiments provide researchers with a wealth of data and knowledge from heterogeneous sources. Analyzed in its entirety, OMICs data provide a deep insight into the overall biological processes of organisms. However, the integration of data from different cellular levels (e.g., transcriptomics and proteomics) is challenging. Analyzing lists of differentially abundant molecules from different cellular levels often results in a small overlap, which can be accounted to, e.g., different regulatory mechanisms, different temporal scales as well as inherent properties of the measurement method. Thus, there is a need for approaches that allow efficient integration of OMICs data from different cellular levels. In this study, we make use of transcriptome, proteome and secretome data from the human pathogenic fungus Aspergillus fumigatus challenged with the antifungal drug caspofungin. Caspofungin targets the fungal cell wall leading to a compensatory stress response. We analyze the experimental data based on two different approaches. First, we apply a simple approach based on the comparison of differentially regulated genes and proteins with subsequent pathway analysis. Second, we compare the cellular levels based on the identification of regulatory or functional modules by two module-detecting algorithms from protein-protein interaction networks in conjunction with transcriptomic and proteomic data. Our results show that both approaches associate the fungal caspofungin response with biological pathways like cell wall biosynthesis, fatty acid metabolism as well as carbohydrate metabolism. Compared to results of the simple approach, the use of regulatory modules shows a notably higher agreement between the different cellular levels. The additional structural information of the networks provided by the module-based approach allows for topological analysis as well as the analysis of the temporal evolution of cellular response at a molecular level. However, we also found that quality of the module-based results depends on the comprehensiveness of the underlying protein-protein interaction network itself. Thus, while our results highlight the benefits and potential provided by a module-based analysis of OMICs data from different cellular levels, future studies will have to focus on the expansion of organism specific protein-protein interaction networks.

			Action	DRS
	1.mgf	Mgf
	1.mzML	Mzml
	1.mzid.gz	Mzid
	1.raw	Raw
	2.mgf	Mgf

Dataset Information

Proteome of candida glabrata after Caspofungin exposure

Dataset's files

Publications

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets